131 related articles for article (PubMed ID: 21924073)
1. [Myocardial perfusion evaluation post percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy by ⁹⁹Tc(m) MIBI SPECT MPI].
Sun XX; Tian YQ; Qiao SB; Yuan JS; Duan FJ; Wang DY; Guo F; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):497-502. PubMed ID: 21924073
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ
Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
5. MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Amano Y; Takayama M; Kumita S; Kumazaki T
J Comput Assist Tomogr; 2007; 31(4):600-4. PubMed ID: 17882040
[TBL] [Abstract][Full Text] [Related]
6. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
7. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
8. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
Du H; Lu M; Yin G; Yin X; Jiang Y; Wang J; Chen X; Song L; Huang J; Zhang Y; Zhao S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):665-9. PubMed ID: 25388340
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
[TBL] [Abstract][Full Text] [Related]
10. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
Chen S; Duan F; Yuan J; Qiao S; Lv X; Hu F; Yang W; Zhang J; Yang Y
Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549
[TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
12. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
13. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Amano Y; Kitamura M; Yamada F; Aita K; Takayama M; Tachi M; Kumita S
Acta Radiol; 2015 Nov; 56(11):1323-8. PubMed ID: 25414371
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy.
Mitsutake R; Miura S; Sako H; Nishikawa H; Saku K
Int J Cardiol; 2008 Sep; 129(2):e61-3. PubMed ID: 17888532
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
Faber L; Seggewiss H; Gleichmann U
Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
[TBL] [Abstract][Full Text] [Related]
17. [The effect on electrocardiographic and cardiac autonomic function after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy].
Xing YB; Guo HY; Wang P; You BQ; Chen JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):731-4. PubMed ID: 17963633
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ
Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385
[TBL] [Abstract][Full Text] [Related]
20. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
van Dockum WG; ten Cate FJ; ten Berg JM; Beek AM; Twisk JW; Vos J; Hofman MB; Visser CA; van Rossum AC
J Am Coll Cardiol; 2004 Jan; 43(1):27-34. PubMed ID: 14715178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
